Vertex Enters Into Agreement to Acquire Alpine Immune Sciences : vimarsana.com

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Alpine Immune Sciences, Inc. (Nasdaq: ALPN), a biotechnology company focused on discovering and developing innovative, protein-based immunotherapies, today announced that the companies have entered into a definitive agreement under which Vertex will acquire ...

Related Keywords

Boston , Massachusetts , United States , Australia , London , City Of , United Kingdom , America , Meagher Flom , Reshma Kewalramani , Adams Merger Sub Inc , Nasdaq , Fenwick West , Youtube , Linkedin , Companies To Work , Exchange Commission , Facebook , Vertex Pharmaceuticals Conference Call , Lazard , Vertex Pharmaceuticals Incorporated Nasdaq , Alpine Immune Sciences Inc , Vertex Pharmaceuticals Incorporated , Instagram , Alpine Immune Sciences , Alpine Boards , Through Phase , Chief Executive Officer , Executive Chairman , Hart Scott Rodino Antitrust Improvements Act , For Alpine , Centerview Partners , Iga Nephropathy , Conference Call , Pharmaceuticals Conference Call , North America , Latin America , Science Magazine , Top Employers , Recommendation Statement , Tender Offer Materials , Adams Merger Sub , Tender Offer Statement , Tender Offer ,